Home Evaluation of vaccine potency and cross-protection between FMDV serotypes O, A, and SAT2

Projects

Evaluation of vaccine potency and cross-protection between FMDV serotypes O, A, and SAT2

Principle Investigator(s)

Planned Completion date: 01/01/2025

Project Status

Active

Principal Investigator(s)

Defra

Researcher Organisations

Pirbright Institute

Source Country

UK